| Particulars (Rupees in Crores.) | Mar-2025 | Sept-2024 | Mar-2024 | Sept-2023 | Mar-2023 |
|---|---|---|---|---|---|
Gross Sales | 26,583.1 | 21,758.66 | 24,490.83 | 21,026.43 | 23,500.78 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 26,583.1 | 21,758.66 | 24,490.83 | 21,026.43 | 23,500.78 |
Other Operating Income | 107.66 | 85.72 | 92.15 | 93.93 | 101.51 |
Other Income | 97.19 | 308.25 | 154.48 | 89.78 | 118.52 |
Total Income | 26,787.95 | 22,152.63 | 24,737.46 | 21,210.14 | 23,720.81 |
Total Expenditure | 21,363.55 | 17,963.84 | 20,152.31 | 17,779.68 | 20,285.74 |
PBIDT | 5,424.4 | 4,188.79 | 4,585.15 | 3,430.46 | 3,435.07 |
Interest | 2,064.09 | 1,866.12 | 1,611.96 | 1,370.29 | 1,127.32 |
PBDT | 3,360.31 | 2,322.67 | 2,973.19 | 2,060.17 | 2,307.75 |
Depreciation | 607.5 | 479.15 | 473.79 | 453.5 | 479.18 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 1,071.59 | 654.27 | 876.69 | 602.22 | 737.49 |
Deferred Tax | -384.37 | -127.95 | 80.17 | -149.35 | -62.84 |
Reported Profit After Tax | 2,065.59 | 1,317.2 | 1,542.54 | 1,153.8 | 1,153.92 |
Minority Interest After NP | 173.58 | 102.41 | 128.92 | 83.9 | 82.35 |
Net Profit after Minority Interest | 1,892.01 | 1,214.79 | 1,413.62 | 1,069.9 | 1,071.57 |
Extra-ordinary Items | -108.5 | 79.93 | -52.99 | -19.52 | 62.05 |
Adjusted Profit After Extra-ordinary item | 2,000.51 | 1,134.86 | 1,466.61 | 1,089.42 | 1,009.52 |
EPS (Unit Curr.) | 6.44 | 4.14 | 4.81 | 3.64 | 3.65 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 200 | 0 | 0 | 0 |
Equity | 293.65 | 293.64 | 293.63 | 293.61 | 293.61 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 20.4 | 19.25 | 18.72 | 16.31 | 14.61 |
PBDTM(%) | - | - | - | - | - |
PATM(%) | 7.77 | 6.05 | 6.29 | 5.48 | 4.91 |
The quarterly EBITDA of the company has reached ₹1,791 crore, with a 12.5% year-on-year growth due to stable operating activities and maintained cost efficiency.
The company has not yet determined the record date for deciding the entitlement of the shareholders to receive bonus shares in due course.
Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.
The newly awarded contracts will help enable troop transportation, logistics & other specialized mobility requirements in support of the CIWS programme
Ashok Leyland’s revenue for the December quarter grew 2.2% to ₹9,478.7 crore as compared with ₹9,273 crore in the year-ago fiscal.
The company's total sales increased 5%, while medium and heavy commercial vehicle (M&HCV) sales increased 8% year on year.
The order value, the company said in its filings, is about ₹345.58 crore.
The stock has gained a total of 24% in the last one year, and 16% since the beginning of the year.
During the given period, the overall sales of light commercial vehicles (including domestic and exports) decreased by 12% year over year to 5,902 units.
The order includes 400 non-AC buses, and 100 air-conditioned buses, each designed to seat 37 passengers with additional standing space for 24.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
